← Open Payments lookup

MICHAEL GONZALEZ: Open Payments

NPI 1942536313 · ELSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$902 in 45 payments from 10 companies in 2025. Trend: 2023 $402 · 2024 $535 · 2025 $902

Food & beverage: $902
CompanyPaymentsAmount
Amgen Inc.13$181
Bayer Healthcare Pharmaceuticals Inc.9$167
Lilly USA, LLC6$119
Zimmer Biomet Holdings, Inc.1$103
Boehringer Ingelheim Pharmaceuticals, Inc.4$101
AstraZeneca Pharmaceuticals LP5$97
Abbott Laboratories3$55
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$31
Novo Nordisk Inc1$26
Sumitomo Pharma America, Inc.1$23

Products named: OTEZLA, Kerendia, MOUNJARO, Gel-One Cross-linked Hyaluronate, JARDIANCE, FARXIGA, FREESTYLE LIBRE 3, XIFAXAN.

Industry payments across TX — which companies pay providers there.